Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 2
2014 1
2017 2
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Sex differences in COVID-19 mortality in the Netherlands.
Niessen A, Teirlinck AC, McDonald SA, van der Hoek W, van Gageldonk-Lafeber R; RIVM COVID-19 epidemiology, surveillance group; Knol MJ. Niessen A, et al. Among authors: van gageldonk lafeber r. Infection. 2022 Jun;50(3):709-717. doi: 10.1007/s15010-021-01744-0. Epub 2022 Feb 9. Infection. 2022. PMID: 35138581 Free PMC article.
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Kissling E, Hooiveld M, Sandonis Martín V, Martínez-Baz I, William N, Vilcu AM, Mazagatos C, Domegan L, de Lusignan S, Meijer A, Machado A, Brytting M, Casado I, Murray JK, Belhillil S, Larrauri A, O'Donnell J, Tsang R, de Lange M, Rodrigues AP, Riess M, Castilla J, Hamilton M, Falchi A, Pozo F, Dunford L, Cogdale J, Jansen T, Guiomar R, Enkirch T, Burgui C, Sigerson D, Blanchon T, Martínez Ochoa EM, Connell J, Ellis J, van Gageldonk-Lafeber R, Kislaya I, Rose AM, Valenciano M; I-MOVE-COVID-19 primary care study team; I-MOVE-COVID-19 primary care study team (in addition to authors above). Kissling E, et al. Among authors: van gageldonk lafeber r. Euro Surveill. 2021 Jul;26(29):2100670. doi: 10.2807/1560-7917.ES.2021.26.29.2100670. Euro Surveill. 2021. PMID: 34296676 Free PMC article.
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season.
Rondy M, Gherasim A, Casado I, Launay O, Rizzo C, Pitigoi D, Mickiene A, Marbus SD, Machado A, Syrjänen RK, Pem-Novose I, Horváth JK, Larrauri A, Castilla J, Vanhems P, Alfonsi V, Ivanciuc AE, Kuliese M, van Gageldonk-Lafeber R, Gomez V, Ikonen N, Lovric Z, Ferenczi A; I-MOVE+ hospital working group; Moren A. Rondy M, et al. Among authors: van gageldonk lafeber r. Euro Surveill. 2017 Oct;22(41):17-00645. doi: 10.2807/1560-7917.ES.2017.22.41.17-00645. Euro Surveill. 2017. PMID: 29043961 Free PMC article.
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
Rondy M, Larrauri A, Casado I, Alfonsi V, Pitigoi D, Launay O, Syrjänen RK, Gefenaite G, Machado A, Vučina VV, Horváth JK, Paradowska-Stankiewicz I, Marbus SD, Gherasim A, Díaz-González JA, Rizzo C, Ivanciuc AE, Galtier F, Ikonen N, Mickiene A, Gomez V, Kurečić Filipović S, Ferenczi A, Korcinska MR, van Gageldonk-Lafeber R; I-MOVE+ hospital working group; Valenciano M. Rondy M, et al. Among authors: van gageldonk lafeber r. Euro Surveill. 2017 Jul 27;22(30):30580. doi: 10.2807/1560-7917.ES.2017.22.30.30580. Euro Surveill. 2017. PMID: 28797322 Free PMC article.
Transmission of novel influenza A(H1N1) in households with post-exposure antiviral prophylaxis.
van Boven M, Donker T, van der Lubben M, van Gageldonk-Lafeber RB, te Beest DE, Koopmans M, Meijer A, Timen A, Swaan C, Dalhuijsen A, Hahné S, van den Hoek A, Teunis P, van der Sande MA, Wallinga J. van Boven M, et al. Among authors: van gageldonk lafeber rb. PLoS One. 2010 Jul 7;5(7):e11442. doi: 10.1371/journal.pone.0011442. PLoS One. 2010. PMID: 20628642 Free PMC article.
Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014.
Kraaij-Dirkzwager M, Timen A, Dirksen K, Gelinck L, Leyten E, Groeneveld P, Jansen C, Jonges M, Raj S, Thurkow I, van Gageldonk-Lafeber R, van der Eijk A, Koopmans M; MERS-CoV outbreak investigation team of the Netherlands. Kraaij-Dirkzwager M, et al. Among authors: van gageldonk lafeber r. Euro Surveill. 2014 May 29;19(21):20817. doi: 10.2807/1560-7917.es2014.19.21.20817. Euro Surveill. 2014. PMID: 24906375 Free article.
Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van 't Veen A, van der Vries E, te Wierik M, Koopmans M. Meijer A, et al. Among authors: van gageldonk lafeber r. Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004. Epub 2011 Jul 13. Antiviral Res. 2011. PMID: 21767571